Titan Pharmaceuticals Files 2024 10-K
| Field | Detail |
|---|---|
| Company | Titan Pharmaceuticals Inc |
| Form Type | 10-K |
| Filed Date | Mar 20, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, financials, pharmaceuticals
TL;DR
Titan Pharma dropped its 2024 10-K. Check revenue from licenses & grants for 23/24.
AI Summary
Titan Pharmaceuticals Inc. filed its 2024 10-K on March 20, 2025, reporting on its fiscal year ending December 31, 2024. The company, based in San Francisco, CA, operates in the biological products sector. Financial details regarding revenue streams like license and service fees, as well as grants, for the fiscal years 2023 and 2024 are included in the filing.
Why It Matters
This filing provides investors and analysts with a comprehensive overview of Titan Pharmaceuticals' financial performance and business operations for the fiscal year 2024, including key revenue figures.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Titan Pharmaceuticals is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024 — Fiscal Year (Reporting period for the 10-K)
- 2023 — Fiscal Year (Comparative period for financial data)
Key Players & Entities
- TITAN PHARMACEUTICALS INC (company) — Filer
- 2024-12-31 (date) — Fiscal Year End
- 2025-03-20 (date) — Filing Date
- 400 OYSTER POINT BLVD SUITE 505 (address) — Business Address
- SAN FRANCISCO, CA (location) — Business Location
- 6502444990 (phone_number) — Business Phone
FAQ
What were Titan Pharmaceuticals' total revenues for the fiscal year ended December 31, 2024?
The filing indicates revenue data for the fiscal year 2024, including license and service member revenue and grant revenue, but specific total revenue figures are not provided in the extracted text.
What is the primary business of Titan Pharmaceuticals Inc.?
Titan Pharmaceuticals Inc. operates in the Biological Products (No Diagnostic Substances) sector, SIC code 2836.
Where is Titan Pharmaceuticals Inc. headquartered?
Titan Pharmaceuticals Inc. is located at 400 Oyster Point Blvd, Suite 505, San Francisco, CA 94080.
When was this 10-K filing submitted to the SEC?
This 10-K filing was submitted to the SEC on March 20, 2025.
What are the key financial reporting periods covered by this 10-K?
This 10-K covers the fiscal year ended December 31, 2024, and includes comparative data for the fiscal year ended December 31, 2023.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 20, 2025 regarding TITAN PHARMACEUTICALS INC.